Viatrexx-Male Plus
- Product NDC
- 73069-320
- 11-digit product format
- 730690320
- Labeler code
- 73069
- Product ID
- 73069-320_c4ee4ac8-bd4f-4ed1-abd6-7b2726c89bf1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Adrenal gland, Aldosterone, Androsterone, cAMP / Adenosinum cyclophosphoricum, Cholesterinum, DHEA, Growth hormone, Hypothalamus, Melatonin, Pancreas, Pineal, Pituitary, Prostate, Testis, Testosterone, Thalamus, Thymus, Thyroid gland
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR; INTRAVENOUS; PARENTERAL; SUBCUTANEOUS
- Labeler
- VIATREXX BIO INCORPORATED
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2019-03-29
- Marketing end
- 0000-00-00
- Substance
- BOS TAURUS ADRENAL GLAND; SUS SCROFA ADRENAL GLAND; ALDOSTERONE; ANDROSTERONE; ADENOSINE CYCLIC PHOSPHATE; CHOLESTEROL; PRASTERONE; SOMATROPIN; BOS TAURUS HYPOTHALAMUS; SUS SCROFA HYPOTHALAMUS; MELATONIN; BOS TAURUS PANCREAS; SUS SCROFA PANCREAS; BOS TAURUS PINEAL GLAND; SUS SCROFA PINEAL GLAND; BOS TAURUS PITUITARY GLAND; SUS SCROFA PITUITARY GLAND; BOS TAURUS PROSTATE GLAND; SUS SCROFA PROSTATE; BOS TAURUS TESTICLE; SUS SCROFA TESTICLE; TESTOSTERONE; SUS SCROFA THALAMUS; BOS TAURUS THYMUS; THYROID, PORCINE; THYROID, BOVINE
- Active strength
- 201 [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL
- Pharmacologic classes
- Androgen [EPC],Androgen Receptor Agonists [MoA],Androstanes [CS],Recombinant Human Growth Hormone [EPC],Human Growth Hormone [CS]
- DEA schedule
- CIII
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record